Tauopathies and synucleinopathies: Do cerebrospinal fluid β-amyloid peptides reflect disease-specific pathogenesis? (Q58478214)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318305%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318305%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

1 reference

B Mollenhauer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318305%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

M Bibl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318305%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

H Esselmann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318305%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

P Steinacker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318305%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

C Trenkwalder

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318305%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

22 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318305%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neural Transmission

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318305%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318305%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318305%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

919-927

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318305%20AND%20SRC:MED&resulttype=core&format=json

Cultured cell and transgenic mouse models for tau pathology linked to beta-amyloid

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0629-4

Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0629-4

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0629-4

Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0629-4

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0629-4

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0629-4

Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0629-4

Corticobasal degeneration: neuropathologic and clinical heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0629-4

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-007-0629-4

Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide

21 January 2018

1 reference

12 December 2020

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

12 December 2020

Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma

1 reference

12 December 2020

Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43.

1 reference

12 December 2020

What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study

1 reference

12 December 2020

Prevalence of amyloid-beta deposition in the cerebral cortex in Parkinson's disease

1 reference

12 December 2020

Progressive supranuclear palsy and corticobasal degeneration

1 reference

12 December 2020

Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities

1 reference

12 December 2020

Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases

1 reference

12 December 2020

Oxidation of methionine 35 attenuates formation of amyloid beta -peptide 1-40 oligomers

1 reference

12 December 2020

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

1 reference

12 December 2020

Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

1 reference

12 December 2020

Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias

1 reference

12 December 2020

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

12 December 2020

Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice

1 reference

12 December 2020

Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease

1 reference

12 December 2020

Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy

1 reference

12 December 2020

Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease

1 reference

12 December 2020

Lewy bodies in progressive supranuclear palsy

1 reference

12 December 2020

Coexistence of PSP and MSA: a case report and review of the literature

1 reference

12 December 2020

The amyloid deposits in Alzheimer's disease: their nature and pathogenesis

1 reference

12 December 2020

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia

1 reference

12 December 2020

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

12 December 2020

Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders

1 reference

12 December 2020

Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

1 reference

12 December 2020

Deposition of beta-amyloid subtypes 40 and 42 differentiates dementia with Lewy bodies from Alzheimer disease

1 reference

12 December 2020

An autopsy case of Alzheimer's disease with a progressive supranuclear palsy overlap

1 reference

12 December 2020

Self‐oligomerization of NACP, the precursor protein of the non‐amyloid β/A4 protein (Aβ) component of Alzheimer's disease amyloid, observed in the presence of a C‐terminal Aβ fragment (residues 25–35)

1 reference

12 December 2020

Research evaluation and prospective diagnosis of dementia with Lewy bodies.

1 reference

12 December 2020

Alpha-Synuclein aggregation in pathological aging and Alzheimer's disease: the impact of beta-amyloid plaque level

1 reference

12 December 2020

1 reference

12 December 2020

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

1 reference

12 December 2020

Cerebrospinal fluid Abeta42 levels in multiple system atrophy

1 reference

12 December 2020

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

1 reference

12 December 2020

Prevalence of Alzheimer lesions in Parkinson's disease

1 reference

12 December 2020

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

12 December 2020

How to diagnose multiple system atrophy

1 reference

12 December 2020

Study of the conformational transition of A beta(1-42) using D-amino acid replacement analogues

1 reference

12 December 2020

Amyloid beta-peptide and the dementia of Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration.

1 reference

12 December 2020

Electrophoretic mobility of Alzheimer’s amyloid-β peptides in urea–sodium dodecyl sulfate–polyacrylamide gel electrophoresis

1 reference

12 December 2020

Brain Accumulation of Amyloid-beta in Non-Alzheimer Neurodegeneration.

1 reference

12 December 2020

Non-A.beta. Component of Alzheimer's Disease Amyloid (NAC) is Amyloidogenic

1 reference

12 December 2020

Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease

1 reference

12 December 2020

α-Synuclein in Lewy bodies

1 reference

12 December 2020

Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease.

1 reference

12 December 2020

Increased cerebrospinal fluid A beta38/A beta42 ratio in Alzheimer disease

1 reference

12 December 2020

Amyloid ß-peptide and its relationship with dementia in Lewy body disease

1 reference

12 December 2020

Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease

1 reference

12 December 2020

Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease

1 reference

12 December 2020

Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.

1 reference

12 December 2020

Alzheimer's and Parkinson's disease--overlapping or synergistic pathologies?

1 reference

12 December 2020

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation.

1 reference

12 December 2020

Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells.

1 reference

12 December 2020

A case of progressive supranuclear palsy with widespread senile plaques

1 reference

12 December 2020

Cerebrospinal fluid amyloidβ peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier-mediated epitope masking of amyloidβ peptides

1 reference

12 December 2020

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

1 reference

12 December 2020

10.1007/S00702-007-0629-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318305%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318305%20AND%20SRC:MED&resulttype=core&format=json